Jennifer Markarian

CDMOs strive for flexible, adaptable processes and fast tech transfer for manufacturing investigational drug products, including COVID-19 treatments and vaccines.

Modular building and process designs allow faster time to market for COVID-19 vaccines and treatments.

Automation and tools for remote monitoring are finding increased use as pharmaceutical manufacturing adapts to pandemic restrictions.

Polymeric containers offer an alternative to glass.

Rapid scale-up to billions of doses requires collaborative, all-out efforts by innovators, their manufacturing partners, and the entire supply chain.

A device manufacturing process must be carefully designed in the early stages of development to ensure success in commercial manufacturing.

Early adopters and equipment manufacturers refine their equipment and processes, paving the way for broader use.

For certain APIs, including semi-synthetic antibiotics, continuous filtration and drying improves productivity and quality.

Early adopters and equipment manufacturers refine their equipment and processes, paving the way for broader use.

Experts at Hovione describe progress being made in understanding how to optimize continuous processes for oral solid-dosage drug products.

Outsourcing partners provide capacity and tech transfer expertise in the pharmaceutical industry response to the COVID-19 pandemic.

Suppliers address the complexity of supplying disposable components for single-use systems to the global biopharmaceutical manufacturing industry.

Suppliers address complex supply chains for global biopharmaceutical manufacturing using disposable components.

Electronic systems allow biopharma manufacturing companies to meet data integrity requirements and optimize practices.

The process control and automation requirements of single-use systems differ from those of stainless-steel equipment.